NOVITIUM PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?
NOVITIUM PHARMA has sixty-eight approved drugs.
There is one tentative approval on NOVITIUM PHARMA drugs.
Drugs and US Patents for NOVITIUM PHARMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novitium Pharma | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 215043-001 | Apr 20, 2021 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Novitium Pharma | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 215560-002 | Oct 25, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novitium Pharma | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate; hydrochlorothiazide | TABLET;ORAL | 215562-002 | Nov 4, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novitium Pharma | SOVUNA | hydroxychloroquine sulfate | TABLET;ORAL | 214581-001 | Jan 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Novitium Pharma | SIROLIMUS | sirolimus | SOLUTION;ORAL | 211040-001 | Jan 28, 2019 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novitium Pharma | TADALAFIL | tadalafil | TABLET;ORAL | 215949-001 | Mar 3, 2023 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novitium Pharma | CARBAMAZEPINE | carbamazepine | SUSPENSION;ORAL | 214277-001 | Oct 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.